Abstract:PURPOSE: Pancreatic ductal adenocarcinoma (PDAC) is the 4 leading cause of U.S. cancer-related mortality. Currently, patients with PDAC have a dismal prognosis due to a complete lack of effective therapies . Dendritic cells (DC) are one of the most potent antigen-presenting cells (APCs) in the immune system. Development of therapeutic cancer vaccines using DCs loaded with tumor antigens which are transferred to a host enhancing its tumor immune response, is a viable treatment option, however clinical trials have failed to achieve good efficacy. One of the major roadblocks to the development of these immune therapies is the inability to assess effective target acquisition. In this work we demonstrate that ironoxide labeled DCs, loaded with antigens, can be effectively tracked as they “home in” on the lymph nodes 3 . By providing direct MR visualization of DC uptake in lymph node environment one can positively confirm target acquisition and explore the underlying mechanisms more in depth, The research conducted in this work will the development of these cancer vaccines for translational applications METHODS Panc-2 tumor cells (~2 × 10 cells ) were implanted in both right and left flank female C57BL/6 mice and allowed to grow to palpable nodule (~3-5 mm). Bone marrow derived DCs were prepared as described in [1]. After antigen loading as described in [23] DCs were labeled with biocompatible iron nanoparticles FeOLabel-TexasRed (GENOVIS AB, Lund Sweden) as prescribed. Characterization was conducted to evaluate percent of iron and viability of labeled DCs. Iron amount was estimated by MR relaxometry using variable concentration phantoms (0-10 μg/ml). Vaccine administration was performed by injecting the labeled DCs in the left hind footpad of the mice (Three groups: 1) 1e6 cells, 2) 2e6 cells and 3) no cells as control) All MRI experiments (in vitro and ex vivo) were carried out on a Bruker 7 T (Clinscan, Ettlingen, Germany) using multiple spin echo and multiple gradient echo sequences to obtain coronal and axial images of the bilateral popliteal LNs and to generate corresponding parametric maps (Slice Thickness=0.2 mm In plane resolution 0.14 mm) . Animals were scanned at 6 hours and 24 hours after injection of DCs. All physiological parameters were maintained during experiments as prescribed by institutional ACUC standards. Ex vivo assessment of DC loading in popliteal LN was conducted using histological methods for validation of MRI images. Anti-Tumor efficacy of DCs was evaluated using standard vital signs and by measuring tumor volume at different time points following tumor implantation (1,5,10,15,20,25,35 days). RESULTS & DISCUSSION: Shown in Figure 1(a-c) are three coronal T2W images of bilateral popliteal LN’s at different times (a) preinjection of DC’s, (b) 6 hour post and (c) 24 hour post. The left LN exhibits clear signal decrease consistent with migration of iron labeled DC’s (injected in left footpad) while right is unaffected. Prussian blue staining of bilateral popliteal LNs are shown in Fig 1 (d) Right and Fig 1(e) Left, confirming presence of SPIO labeled DC’s in the later (Fig 1(f) is a blow up of region). Also shown in Fig 2 are the tumor size longitudinal measurements for control group compared to group A (1e6 DC’s) and group B (2e6 DC’s) demonstrating the therapeutic efficacy of the treatment

Lactosylated N-Alkyl Polyethylenimine Coated Iron Oxide Nanoparticles Induced Autophagy in Mouse Dendritic Cells.

The Migration of Synthetic Magnetic Nanoparticle Labeled Dendritic Cells into Lymph Nodes with Optical Imaging

Superparamagnetic Iron Oxide Labeling Limits the Efficacy of Rabbit Immature Dendritic Cell Vaccination by Decreasing Their Antigen Uptake Ability in a Lysosome-Dependent Manner

Superparamagnetic Iron Oxide Nanoparticles May Affect Endothelial Progenitor Cell Migration Ability and Adhesion Capacity

Negatively Charged Magnetite Nanoparticle Clusters as Efficient MRI Probes for Dendritic Cell Labeling and In Vivo Tracking

Magnetic resonance and near-infrared imaging using a novel dual-modality nano-probe for dendritic cell tracking in vivo.

In vivo migration of dendritic cells labeled with synthetic superparamagnetic iron oxide.

Influence of synthetic superparamagnetic iron oxide on dendritic cells.

Superparamagnetic MRI Probes for in Vivo Tracking of Dendritic Cell Migration with a Clinical 3 T Scanner.

Magnetic Nanoparticles Enhance the Cellular Immune Response of Dendritic Cell Tumor Vaccines by Realizing the Cytoplasmic Delivery of Tumor Antigens

6617 In vivo cellular MRI monitoring of FeO Labeled DC-based cancer vaccine for immunotherapeutic treatment of pancreatic cancer

Reduction of polyethylenimine-coated iron oxide nanoparticles induced autophagy and cytotoxicity by lactosylation.

Gadolinium-doped Au@prussian blue nanoparticles as MR/SERS bimodal agents for dendritic cell activating and tracking

SPIO Enhance the Cross-Presentation and Migration of DCs and Anionic SPIO Influence the Nanoadjuvant Effects Related to Interleukin-1β

Immune Adjuvant Targeting Micelles Allow Efficient Dendritic Cell Migration to Lymph Nodes for Enhanced Cellular Immunity.

Stem Cell Labeling With Superparamagnetic Iron Oxide Nanoparticles Using Focused Ultrasound And Magnetic Resonance Imaging Tracking

MRI Tracking of Dendritic Cells Loaded with Superparamagnetic Iron Oxide Nanoparticles.

Superparamagnetic Iron Oxide Nanoparticles As Magnetic Resonance Imaging Contrast Agents and Induced Autophagy Response in Endothelial Progenitor Cells.

Magnetic Enrichment of Dendritic Cell Vaccine in Lymph Node with Fluorescent-Magnetic Nanoparticles Enhanced Cancer Immunotherapy.

Remote Magnetic Control of Autophagy in Mouse B-Lymphoma Cells with Iron Oxide Nanoparticles

Iron Oxide Nanoparticles Promote Macrophage Autophagy and Inflammatory Response Through Activation of Toll-Like Receptor-4 Signaling.